IPP Bureau
Zentalis promotes Kevin Bunker to Chief Scientific Officer
By IPP Bureau - September 28, 2022
Dr. Bunker will focus on leading Research and Development (R&D) in San Diego, advancing the preclinical pipeline and optimizing the Company’s Integrated Discovery Engine.
Julie Brown appointed as CFO of GSK
By IPP Bureau - September 28, 2022
Julie Brown is currently Chief Operating and Financial Officer, Burberry Group.
EDQM grants CEP certificate to Supriya Lifescience for Diphenhydramine Hydrochloride
By IPP Bureau - September 28, 2022
This will be an added advantage for Supriya Lifescience Limited in the European market.
Supriya Lifescience appoints Rajeev Kumar Jain as CEO
By IPP Bureau - September 28, 2022
He is a seasoned professional having worked in reputed corporates in API business with over 35+ years of experience covering manufacturing, general management, and business
SRL Diagnostics launches ‘Heart Assure Test’ to predict risk of cardiac event
By IPP Bureau - September 28, 2022
Patients with moderate or elevated risk in the test should immediately consult a cardiologist for further diagnosis and workup
Mylab receives approval for HPV RT-PCR test for cervical cancers
By IPP Bureau - September 28, 2022
‘PathoDetect HPV Detection Test’ detects and discriminates the presence of high-risk HPV strains including 16 and 18 which cause most of the cervical cancers.
LISSUN raises ~$1 million in pre-Seed round from IvyCap Ventures and others
By IPP Bureau - September 28, 2022
Funds raised will be used to develop technology and foster healthcare partnerships
Carbogen Amcis completes Swissmedic inspection of its facility in Vionnaz, Switzerland
By IPP Bureau - September 28, 2022
This inspection continues a series of successful inspections by Swissmedic in Vionnaz with the first inspection in 2015 followed by 2016, 2017 and 2020.
Hester planning capacity expansion for Goat Pox vaccine
By IPP Bureau - September 27, 2022
Further, ICAR-IVRI have jointly developed a Lumpy Skin Disease vaccine and as soon as the technology is made available, Hester will acquire the same and manufacture and commercialize the Lumpy Skin disease Vaccine
There should be no space for fraud in AB-PMJAY: Dr. Mandaviya
By IPP Bureau - September 27, 2022
The second day of Arogya Manthan 2022 had panel discussions with eminent thought leaders from relevant public and private sector organizations
Pfizer and BioNTech submit application to USFDA for emergency use authorization of Omicron BA.4/BA.5-adapted bivalent vaccine booster for 5-11 year age
By IPP Bureau - September 27, 2022
The companies have also initiated a Phase 1/2/3 study NCT05543616 to evaluate the safety, tolerability, and immunogenicity of different doses
Novartis unveils new focused strategy
By IPP Bureau - September 27, 2022
Transformation to pure-play Innovative Medicines company nears completion
CellOrigin Biotech collaborates with Qilu Pharma to develop CAR-iMAC Cell Therapy
By IPP Bureau - September 27, 2022
NATCO launches Chlorantraniliprole (CTPR) formulated product NATGEN
By IPP Bureau - September 26, 2022
NATCO estimates the current market size of CTPR containing products in India to be over Rs. 2,000 crore.
Alkem to spread awareness through “The Healthy Lungs”
By IPP Bureau - September 26, 2022
Though lungs do not have the celebrity status as the heart, they are one of the most important and delicate organs of the human body
